Rice Hall James & Associates LLC Boosts Holdings in Varex Imaging $VREX

Rice Hall James & Associates LLC lifted its holdings in shares of Varex Imaging (NASDAQ:VREX) by 19.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,082,964 shares of the company’s stock after acquiring an additional 173,703 shares during the quarter. Rice Hall James & Associates LLC owned 2.58% of Varex Imaging worth $12,617,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the business. Quarry LP purchased a new position in Varex Imaging in the third quarter valued at about $64,000. BNP Paribas Financial Markets raised its position in shares of Varex Imaging by 18.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after purchasing an additional 2,036 shares in the last quarter. Aquatic Capital Management LLC purchased a new position in shares of Varex Imaging during the 3rd quarter valued at approximately $117,000. Cerity Partners LLC purchased a new position in shares of Varex Imaging during the 2nd quarter valued at approximately $123,000. Finally, Legato Capital Management LLC acquired a new stake in shares of Varex Imaging during the third quarter worth approximately $125,000.

Insider Buying and Selling

In other Varex Imaging news, Director Jay K. Kunkel sold 4,510 shares of Varex Imaging stock in a transaction that occurred on Friday, March 20th. The stock was sold at an average price of $11.14, for a total value of $50,241.40. Following the completion of the transaction, the director directly owned 23,450 shares in the company, valued at $261,233. The trade was a 16.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 4.60% of the stock is currently owned by insiders.

Analyst Ratings Changes

VREX has been the topic of several recent analyst reports. Zacks Research raised shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a report on Monday, April 13th. Wall Street Zen downgraded shares of Varex Imaging from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a research note on Friday, March 27th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $16.17.

Varex Imaging Stock Performance

Varex Imaging stock opened at $10.44 on Tuesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 1.43. Varex Imaging has a 12 month low of $6.76 and a 12 month high of $14.56. The company has a fifty day moving average price of $10.83 and a two-hundred day moving average price of $11.88. The company has a market cap of $439.52 million, a PE ratio of -5.22 and a beta of 0.91.

Varex Imaging (NASDAQ:VREX) last issued its earnings results on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). Varex Imaging had a positive return on equity of 8.19% and a negative net margin of 9.64%.The business had revenue of $216.00 million for the quarter, compared to analyst estimates of $216.92 million. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. Research analysts expect that Varex Imaging will post 0.93 earnings per share for the current year.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.